Biobank Sweden is not a biobank but a national infrastructure for biobanking where healthcare, academia, industry, and patient organisations collaborate to attain good healthcare and research.
Here on our website you can find information and documents regarding how to access samples in Swedish biobanks for research, method development or clinical trials.
Biobank Sweden’s management team has, after careful consideration, decided to remove form N3. The document has previously been used to report on completed sampling in multi centre studies. It has emerged that these reports constitute an obstacle, both for researchers and sponsors, as well as for Regional Biobank Centres (RBCs) and E-biobank managers, who have […]
Read more
Biobank Sweden has secured project funding through Swelife to ensure a continued development of the successful model ‘healthcare integrated biobanking’. The project which will go on until 2026, aims to increase the efficiency of the national model and thereby strengthening medical research while also contributing to equal care and health benefits in Sweden. Healthcare integrated […]
Read more
The Swedish principle for multicentre studies involving biobank samples, came to an end in July due to the new Swedish Biobank Act. The multicentre principle was originally developed by Biobank Sweden to match the requirements in the former Swedish Biobank Act (2002:297). In 2003, when the first Swedish Biobank Act came into force, the national […]
Read more
In these interviews, reseachers share their personal reflections on how biobanks aid research and the development of improved healthcare.
Here you can see our upcoming webinars, conferences, courses and more!
1 September 2025
Online
This webinar introduces the Precision Omics Initiative Sweden (PROMISE), which aims to expand biobank resources, integrate genomic data into healthcare, and establish a sustainable framework for precision medicine research. Save the date!
1 September 2025
Online
9 September 2025
Online
A talk by Lara Bloom. Lara Bloom is the President and CEO of The Ehlers-Danlos Society and responsible for globally raising awareness of rare, chronic, and invisible diseases, specializing in the Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), and related conditions. Lara leads coordinated medical collaboration, raising funds for research and focuses on global progression, […]
9 September 2025
Online
Then you can search here. Filter the results by choosing pages, documents, news posts or calendar.
